Toward intradermal vaccination: preparation of powder formulations by collapse freeze-drying

References

• WHO. Safety of injections: global facts and figures. Geneva: World Health Organization; 2004
   Google Scholar
• Kermode M. Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. Health Promot Int 2004;19:95–103
   PubMed Web of Science ®Google Scholar
• Mitragotri S. Immunization without needles. Nat Rev Immunol 2005;5:905–16
   PubMed Web of Science ®Google Scholar
• Chen D, Maa Y-F, Haynes JR. Needle-free epidermal powder immunization. Expert Rev Vaccines 2002;1:265–76
   PubMedGoogle Scholar
• Ziegler A, Simon S, Lee G. Comminution of carbohydrate and protein microparticles on firing in a ballistic powder injector. J Pharm Sci 2010;99:4917–27
   PubMedGoogle Scholar
• Schiffter H, Condliffe J, Vonhoff S. Spray-freeze-drying of nanosuspensions: the manufacture of insulin particles for needle-free ballistic powder delivery. J R Soc Interface 2010;7:483–500
   Web of Science ®Google Scholar
• Maa Y-F, Ameri M, Shu C, et al. Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation. J Pharm Sci 2004;93:1912–23
   PubMed Web of Science ®Google Scholar
• Maa Y-F, Ameri M, Shu C, et al. Hepatitis-B surface antigen (HBsAg) powder formulation: process and stability assessment. Curr Drug Deliv 2007;4:57–67
   PubMedGoogle Scholar
• Maa Y-F, Zhao L, Payne LG, Chen D. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application. J Pharm Sci 2002;92:319–32
   Google Scholar
• Sonner C, Maa Y-F, Lee G. Spray-freeze-drying for protein powder preparation: particle characterization and a case study with trypsinogen stability. J Pharm Sci 2002;91:2122–39
   PubMed Web of Science ®Google Scholar
• Rochelle C, Lee G. Dextran or hydroxyethyl starch in spray-freeze-dried trehalose/mannitol microparticles intended as ballistic particulate carriers for proteins. J Pharm Sci 2007;96:2296–309
   PubMed Web of Science ®Google Scholar
• Chen D, Endres RL, Erickson CA, et al. Epidermal immunization by a needle-free powder delivery technology: immunogenicity of influenza vaccine and protection in mice. Nat Med 2000;6:1187–90
   PubMed Web of Science ®Google Scholar
• Hardy MP, Kendall MAF. Mucosal deformation from an impinging transonic gas jet and the ballistic impact of microparticles. Phys Med Biol 2005;50:4567
   PubMed Web of Science ®Google Scholar
• Chen D, Erickson CA, Endres RL, et al. Adjuvantation of epidermal powder immunization. Vaccine 2001;19:2908–17
   PubMed Web of Science ®Google Scholar
• Costantino HR, Firouzabadian L, Hogeland K, et al. Protein spray-freeze drying: effect of atomization conditions on particle size and stability. Pharm Res 2000;17:1374–82
   PubMed Web of Science ®Google Scholar
• Maa YF, Ameri M, Shu C, et al. Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation. J Pharm Sci 2004;93:1912–23
   PubMed Web of Science ®Google Scholar
• Shire SJ, Shahrokh Z, Liu J. Challenges in the development of high protein concentration formulations. J Pharm Sci 2004;93:1390–402
   PubMed Web of Science ®Google Scholar
• Amorij J-P, Hinrichs WLJ, Frijlink HW, et al. Needle-free influenza vaccination. Lancet Infect Dis 2010;10:699–711
   PubMed Web of Science ®Google Scholar
• Noh Y-W, Jang Y-S, Ahn K-J, et al. Simultaneous in vivo tracking of dendritic cells and priming of an antigen-specific immune response. Biomaterials 2011;32:6254–63
   PubMed Web of Science ®Google Scholar
• Schersch K, Betz O, Garidel P, et al. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins, part 1: stability after freeze-drying. J Pharm Sci 2010;99:2256–78
   PubMed Web of Science ®Google Scholar
• Schersch K, Betz O, Garidel P, et al. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins, part 2: stability during storage at elevated temperatures. J Pharm Sci 2012;101:2288–306
   PubMed Web of Science ®Google Scholar
• de Groot J, de Jongh HHJ. The presence of heat-stable conformers of ovalbumin affects properties of thermally formed aggregates. Protein Eng 2003;16:1035–40
   PubMedGoogle Scholar
• Bajaj H, Sharma V, Badkar A, et al. Protein structural conformation and not second virial coefficient relates to long-term irreversible aggregation of a monoclonal antibody and ovalbumin in solution. Pharm Res 2006;23:1382–94
   PubMed Web of Science ®Google Scholar
• Tang X, Pikal M. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharm Res 2004;21:191–200
   PubMed Web of Science ®Google Scholar
• Rambhatla S, Ramot R, Bhugra C, Pikal M. Heat and mass transfer scale-up issues during freeze drying: II: control and characterization of the degree of supercooling. AAPS PharmSciTech 2004;5:54–62
   Web of Science ®Google Scholar
• Konstantinidis AK, Kuu W, Otten L, et al. Controlled nucleation in freeze-drying: effects on pore size in the dried product layer, mass transfer resistance, and primary drying rate. J Pharm Sci 2011;100:3453–70
   PubMed Web of Science ®Google Scholar
• Maa Y-F, Prestrelski SJ. Biopharmaceutical powders: particle formation and formulation considerations. Curr Pharm Biotechnol 2000;1:283–302
   PubMedGoogle Scholar
• Strickland WA. Study of water vapor sorption by pharmaceutical powders. J Pharm Sci 1962;51:310–14
   PubMed Web of Science ®Google Scholar
• Fakes MG, Dali MV, Haby TA, et al. Moisture sorption behavior of selected bulking agents used in lyophilized products. PDA J Pharm Sci Technol 2000;54:144–9
   PubMedGoogle Scholar
• Abdul-Fattah A, Truong-Le V, Yee L, et al. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability II: stability of a vaccine. Pharm Res 2007;24:715–27
   PubMed Web of Science ®Google Scholar
• Costantino HR, Firouzabadian L, Wu C, et al. Protein spray freeze drying. 2. Effect of formulation variables on particle size and stability. J Pharm Sci 2002;91:388–95
   PubMed Web of Science ®Google Scholar
• Bam NB, Cleland JL, Yang J, et al. Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. J Pharm Sci 1998;87:1554–9
   PubMed Web of Science ®Google Scholar
• Serno T. Inhibition of therapeutic protein aggregation by cyclodextrins [PhD thesis]. Munich: Ludwigs-Maximilians-University; 2010
   Google Scholar